Evoke Pharma Announces Senior Leadership Transition with Promotion of Matthew J. D'Onofrio to Chief Executive Officer
Evoke Pharma(EVOK) Newsfilter·2024-03-22 04:15公司任命 - Evoke Pharma, Inc.宣布Matthew J. D'Onofrio将接替David A. Gonyer成为首席执行官[1] 使命宣言 - Matthew J. D'Onofrio表示将继续致力于推广GIMOTI治疗糖尿病胃轻瘫的使命[2] 公司业务 - Evoke Pharma专注于治疗胃肠道疾病，已成功开发并推出GIMOTI鼻喷剂[3]